Lymphoma, Low-Grade Clinical Trial
Official title:
Phase III Study of Treatment of Localized Lymphomas: Radiotherapy Versus Radio-Chemotherapie
To compare localiezd radiotherapy to localized radiotherapy followed by 6 cycles of chemotherapy in the treatment of localiezd low grade lymphoma
The standard treatment ol localized low grade lymphomas is Radiotherapy alone can offer long
term remissions to some patients .
No study have clearly demonstrated the interest of chemotherapy. The purpose of the study is
to determine wether prednisone administrated after first line local radiotherapy (30 GY) can
pre in the treatment of localized low grade lymphomas of adult patients
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00317096 -
FCM Versus R-FCM Followed by R-Maintenance or Observation Only
|
Phase 3 | |
| Completed |
NCT00051025 -
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
|
Phase 2 | |
| Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
| Active, not recruiting |
NCT00036426 -
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
|
Phase 2 | |
| Terminated |
NCT00143884 -
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
|
Phase 2 | |
| Withdrawn |
NCT01263418 -
Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas
|
Phase 2 | |
| Completed |
NCT00168727 -
Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma
|
Phase 4 | |
| Completed |
NCT00546793 -
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
|
Phase 1/Phase 2 | |
| Terminated |
NCT00060671 -
Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
|
Phase 3 | |
| Completed |
NCT00311129 -
Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
|
Phase 2 | |
| Completed |
NCT00060684 -
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
|
Phase 1 | |
| Active, not recruiting |
NCT01181271 -
Tandem Auto-Allo Transplant for Lymphoma
|
Phase 2 | |
| Completed |
NCT00220285 -
Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
|
Phase 2 | |
| Terminated |
NCT00038883 -
Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
|
N/A | |
| Completed |
NCT00143845 -
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
|
Phase 2 |